BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: So-Armah K, Freiberg MS. HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers. Curr HIV/AIDS Rep 2018;15:233-44. [PMID: 29752699 DOI: 10.1007/s11904-018-0400-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database. J Am Heart Assoc 2019;8:e012241. [PMID: 31266386 DOI: 10.1161/JAHA.119.012241] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 9.3] [Reference Citation Analysis]
2 Wu KC, Haberlen SA, Plankey MW, Palella FJ, Piggott DA, Kirk GD, Margolick JB, Post WS. Human immunodeficiency viral infection and differences in interstitial ventricular fibrosis and left atrial size. Eur Heart J Cardiovasc Imaging 2021;22:888-95. [PMID: 33693554 DOI: 10.1093/ehjci/jeab037] [Reference Citation Analysis]
3 Alvarado GR, Usry CR, Gore RS, Watts JA, Okulicz JF. Echocardiographic assessment of asymptomatic US Air Force members with early HIV infection. BMC Res Notes 2019;12:783. [PMID: 31783911 DOI: 10.1186/s13104-019-4822-y] [Reference Citation Analysis]
4 Kuate LM, Tchuisseu LAK, Jingi AM, Kouanfack C, Endomba FT, Ouankou CN, Ngarka L, Noubiap JJ, Kingue S, Menanga A, Zogo PO. Cardiovascular risk and stroke mortality in persons living with HIV: a longitudinal study in a hospital in Yaounde. Pan Afr Med J 2021;40:8. [PMID: 34650658 DOI: 10.11604/pamj.2021.40.8.30855] [Reference Citation Analysis]
5 Doria de Vasconcellos H, Post WS, Ervin AM, Haberlen SA, Budoff M, Malvestutto C, Magnani JW, Feinstein MJ, Brown TT, Lima JAC, Wu KC. Associations Between HIV Serostatus and Cardiac Structure and Function Evaluated by 2-Dimensional Echocardiography in the Multicenter AIDS Cohort Study. J Am Heart Assoc 2021;10:e019709. [PMID: 33749311 DOI: 10.1161/JAHA.120.019709] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Bonou M, Kapelios CJ, Athanasiadi E, Mavrogeni SI, Psichogiou M, Barbetseas J. Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV. Vasc Med 2021;26:326-37. [PMID: 33475050 DOI: 10.1177/1358863X20978702] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gonçalves AJ, Braga MVA, Santana PH, Resende LAPR, da Silva VJD, Correia D. Linear and non-linear analysis of heart rate variability in HIV-positive patients on two different antiretroviral therapy regimens. BMC Infect Dis 2021;21:1022. [PMID: 34587909 DOI: 10.1186/s12879-021-06648-w] [Reference Citation Analysis]
8 Dai L, Liu A, Zhang H, Wu H, Zhang T, Su B, Shao Y, Li J, Ye J, Scott SR, Mahajan SD, Schwartz SA, Yu H, Sun L. Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study. Curr HIV Res 2019;17:324-34. [PMID: 31654514 DOI: 10.2174/1570162X17666191025115508] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bavaro DF, Laghetti P, Poliseno M, De Gennaro N, Di Gennaro F, Saracino A. A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV. Diagnostics (Basel) 2021;11:2047. [PMID: 34829394 DOI: 10.3390/diagnostics11112047] [Reference Citation Analysis]
10 Pawlos A, Broncel M, Wlazłowska E, Jabłonowska E, Gorzelak-Pabiś P. Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations. PLoS One 2020;15:e0244675. [PMID: 33373417 DOI: 10.1371/journal.pone.0244675] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Boeckmans J, Rombaut M, Demuyser T, Declerck B, Piérard D, Rogiers V, De Kock J, Waumans L, Magerman K, Cartuyvels R, Rummens JL, Rodrigues RM, Vanhaecke T. Infections at the nexus of metabolic-associated fatty liver disease. Arch Toxicol 2021;95:2235-53. [PMID: 34027561 DOI: 10.1007/s00204-021-03069-1] [Reference Citation Analysis]
12 Rwegerera GM, Shailemo DHP, Pina Rivera Y, Mokgosi KO, Bale P, Oyewo TA, Luis BD, Habte D, Godman B. Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana. Diabetes Metab Syndr Obes 2021;14:85-97. [PMID: 33469326 DOI: 10.2147/DMSO.S285720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fidel PL Jr, Moyes D, Samaranayake L, Hagensee ME. Interplay between oral immunity in HIV and the microbiome. Oral Dis 2020;26 Suppl 1:59-68. [PMID: 32862522 DOI: 10.1111/odi.13515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Pérez-gonzález A, Suárez-garcía I, Ocampo A, Poveda E. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges. Microorganisms 2022;10:433. [DOI: 10.3390/microorganisms10020433] [Reference Citation Analysis]
15 Attin M, Abiola S, Magu R, Rosero S, Apostolakos M, Groth CM, Block R, Lin CDJ, Intrator O, Hurley D, Arcoleo K. Polypharmacy prior to in-hospital cardiac arrest among patients with cardiopulmonary diseases: A pilot study. Resusc Plus 2020;4:100026. [PMID: 33969325 DOI: 10.1016/j.resplu.2020.100026] [Reference Citation Analysis]
16 Ogunleye OO, Basu D, Mueller D, Sneddon J, Seaton RA, Yinka-Ogunleye AF, Wamboga J, Miljković N, Mwita JC, Rwegerera GM, Massele A, Patrick O, Niba LL, Nsaikila M, Rashed WM, Hussein MA, Hegazy R, Amu AA, Boahen-Boaten BB, Matsebula Z, Gwebu P, Chirigo B, Mkhabela N, Dlamini T, Sithole S, Malaza S, Dlamini S, Afriyie D, Asare GA, Amponsah SK, Sefah I, Oluka M, Guantai AN, Opanga SA, Sarele TV, Mafisa RK, Chikowe I, Khuluza F, Kibuule D, Kalemeera F, Mubita M, Fadare J, Sibomana L, Ramokgopa GM, Whyte C, Maimela T, Hugo J, Meyer JC, Schellack N, Rampamba EM, Visser A, Alfadl A, Malik EM, Malande OO, Kalungia AC, Mwila C, Zaranyika T, Chaibva BV, Olaru ID, Masuka N, Wale J, Hwenda L, Kamoga R, Hill R, Barbui C, Bochenek T, Kurdi A, Campbell S, Martin AP, Phuong TNT, Thanh BN, Godman B. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front Pharmacol 2020;11:1205. [PMID: 33071775 DOI: 10.3389/fphar.2020.01205] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]